The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples